Home – refresh2021-05-25T13:26:00-07:00

Degrading Proteins

Saving Lives
We are a clinical-stage company harnessing our deep expertise in Targeted Protein Degradation to restore protein homeostasis in order to treat a wide range of diseases.

We are Proven
Drug Developers

We are pioneers. We wrote the book on Targeted Protein Degradation with the development of the IMiDs, one of the most successful anti-cancer franchises in history. We have brought this unmatched expertise to bear at BioTheryX in the development of novel therapeutics for oncology and inflammatory diseases.

Get to Know Us

We Treat Diseases
with Protein Degradation

Our technology uses Targeted Protein Degradation with our novel, small molecule PHM® ‘molecular glues’, that regulate protein equilibrium. PHMs have potential applicability to a very broad range of disease targets, including those that have to date been considered undruggable.

Our initial programs are focused on protein degradation and multi-kinase inhibition to treat serious cancers AML and MDS.

Our Science in Action

We Treat Diseases
with Protein Degradation

Our technology uses Targeted Protein Degradation with our novel, small molecule PHM® ‘molecular glues’, that regulate protein equilibrium. PHMs have potential applicability to a very broad range of disease targets, including those that have to date been considered undruggable.

Our initial programs are focused on protein degradation and multi-kinase inhibition to treat serious cancers AML and MDS.

Our Science in Action
Go to Top